SMARCA4 deficient tumors are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade
FI: 14,919
Type: Article
Collaboration
Year: 2021
Writers
Romero, OA; Vilarrubi, A; Alburquerque-Bejar, JJ; Gomez, A; Andrades, A; Trastulli, D; Pros, E; Setien, F; Vegetables; Farre, L.; Martin-Tejera, JF; Llabata, P; Oakin, A; Saigi, M; Piulats, JM; Matias-Guiu, X; Medina, PP; Vidal, A; Villanueva, A; Sanchez-
Magazine
Title: NATURE COMMUNICATIONS
Quartile
- D1